December 4, 2014BloodOpen Access

Five hematologic tests and treatments to question

View Full Paper

Ask AI

Bookmark

Population

Patients with specific hematologic conditions.

Design

Guideline

Authors

LHLisa K. HicksSt. Michael's Hospital HBHarriet BeringBedford Research Foundation KCKenneth R. CarsonNorthwestern University

Discussion

Member takes

Implication

Supports limiting anticoagulation to 3 months in provoked VTE and HIT testing to high-probability cases; reinforces evidence-based de-implementation in hematology.

Structured PICO

Population

Patients with specific hematologic conditions (first venous thromboembolic event with major transient risk factors, sickle cell disease, asymptomatic early-stage chronic lymphocytic leukemia, suspected heparin-induced thrombocytopenia with low pretest probability, and immune thrombocytopenia).

Intervention

Five hematologic tests and treatments to question (prolonged anticoagulation, routine transfusion, baseline/surveillance CT scans, HIT testing/treatment, and ITP treatment).

The ASH 2014 Choosing Wisely list provides five evidence-based recommendations to reduce unnecessary hematologic tests and treatments, including avoiding prolonged anticoagulation for provoked VTE.

Cite This Study

Hicks et al. (2014) studied this question.

synapsesocial.com/papers/6a70812afe4101aa97e032ab https://doi.org/10.1182/blood-2014-09-599399

View Full Paper

Ask AI

Bookmark

Implication

Supports limiting anticoagulation to 3 months in provoked VTE and HIT testing to high-probability cases; reinforces evidence-based de-implementation in hematology.